Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom
Go back to Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom| (NASDAQ: RNTX) | Delayed: 0.80 -0.02 (2.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.82 | 52 Week High | $ | |||
| Open | $0.80 | 52 Week Low | $ | |||
| Day High | $0.82 | P/E | N/A | |||
| Day Low | $0.80 | EPS | $ | |||
| Volume | 9,234 | |||||

